Lovrečić L - Search Results

1

Diagnostic efficacy and new variants in isolated and complex autism spectrum disorder using molecular karyotyping.

Lovrečić L, Rajar P, Volk M, Bertok S, Gnidovec Stražišar B, Osredkar D, Jekovec Vrhovšek M, Peterlin B. Lovrečić L, et al. J Appl Genet. 2018 May;59(2):179-185. doi: 10.1007/s13353-018-0440-y. Epub 2018 Mar 21. J Appl Genet. 2018. PMID: 29564645

2

Human Y-specific STR haplotypes in the Western Croatian population sample.

Lovrecić L, Ristić S, Brajenović B, Kapović M, Peterlin B. Lovrecić L, et al. Forensic Sci Int. 2005 May 10;149(2-3):257-61. doi: 10.1016/j.forsciint.2004.06.026. Forensic Sci Int. 2005. PMID: 15749369

3

Region with persistent high frequency of multiple sclerosis in Croatia and Slovenia.

Peterlin B, Ristić S, Sepcić J, Vracko BK, Rako A, Lovrecić L, Brajenović-Milić B, Rudez J, Materljan E, Kapović M. Peterlin B, et al. Among authors: lovrecic l. J Neurol Sci. 2006 Sep 25;247(2):169-72. doi: 10.1016/j.jns.2006.04.002. Epub 2006 Jun 27. J Neurol Sci. 2006. PMID: 16806273

4

Heterogeneity of the triple A syndrome and assessment of a case.

Lovrecić L, Pelet A, Peterlin B. Lovrecić L, et al. Genet Couns. 2006;17(2):191-5. Genet Couns. 2006. PMID: 16970037

5

Angiotensin-converting enzyme I/D gene polymorphism and risk of multiple sclerosis.

Lovrecić L, Ristić S, Starcević-Cizmarević N, Jazbec SS, Sepcić J, Kapović M, Peterlin B. Lovrecić L, et al. Acta Neurol Scand. 2006 Dec;114(6):374-7. doi: 10.1111/j.1600-0404.2006.00711.x. Acta Neurol Scand. 2006. PMID: 17083336

6

PAI and TPA gene polymorphisms in multiple sclerosis.

Lovrecic L, Ristić S, Starcević-Cizmarević N, Brajenović-Milić B, Jazbec SS, Sepcić J, Kapović M, Peterlin B. Lovrecic L, et al. Mult Scler. 2008 Mar;14(2):243-7. doi: 10.1177/1352458507082603. Epub 2007 Nov 6. Mult Scler. 2008. PMID: 17986506

7

Epidemiology of Huntington's disease in Slovenia.

Peterlin B, Kobal J, Teran N, Flisar D, Lovrecić L. Peterlin B, et al. Among authors: lovrecic l. Acta Neurol Scand. 2009 Jun;119(6):371-5. doi: 10.1111/j.1600-0404.2008.01110.x. Epub 2008 Oct 22. Acta Neurol Scand. 2009. PMID: 18976322

8

Interstitial deletion 2p11.2-p12: further delineation.

Writzl K, Lovrecić L, Peterlin B. Writzl K, et al. Among authors: lovrecic l. Am J Med Genet A. 2009 Oct;149A(10):2324-6. doi: 10.1002/ajmg.a.33064. Am J Med Genet A. 2009. PMID: 19764038 No abstract available.

9

Gene expression changes in blood as a putative biomarker for Huntington's disease.

Lovrecic L, Kastrin A, Kobal J, Pirtosek Z, Krainc D, Peterlin B. Lovrecic L, et al. Mov Disord. 2009 Nov 15;24(15):2277-81. doi: 10.1002/mds.22477. Mov Disord. 2009. PMID: 19844910

10

ADP-ribosylation factor guanine nucleotide-exchange factor 2 (ARFGEF2): a new potential biomarker in Huntington's disease.

Lovrecic L, Slavkov I, Dzeroski S, Peterlin B. Lovrecic L, et al. J Int Med Res. 2010 Sep-Oct;38(5):1653-62. doi: 10.1177/147323001003800510. J Int Med Res. 2010. PMID: 21309479 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

61 results

Search Page

Filters